Clinical Trial Update: Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating short-term intensive insulin sequential exenatide therapy in newly diagnosed Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin (insulin)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED